Concepedia

Thomas M. Bridges

TM

Statistics

Publications

78

Citations

4K

H-Index

37

Active since

1980

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

John F. Kennedy Center for the Performing Arts

AstraZeneca (United States)

VA Tennessee Valley Healthcare System

Thomas M. Bridges is an author at Vanderbilt University specializing in pharmacology, neuropharmacology, and drug discovery.

ORCID

Publications per year

1980–2024

78

Publications

78

Novel Selective Allosteric Activator of the M<sub>1</sub>Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats

Carrie K. Jones, Ashley E. Brady, Albert A. Davis et al. · Journal of Neuroscience · 2008 · 244 citations · Full text

, , +16

A Selective Allosteric Potentiator of the M<sub>1</sub>Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning

Jana K. Shirey, Ashley E. Brady, Paulianda J. Jones et al. · Journal of Neuroscience · 2009 · 238 citations · Full text

, , +17

Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats

Ashley E. Brady, Carrie K. Jones, Thomas M. Bridges et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 203 citations · Full text

, , +17

Selective Activation of M<sub>4</sub>Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents

Michael Bubser, Thomas M. Bridges, Ditte Dencker et al. · ACS Chemical Neuroscience · 2014 · 155 citations · Full text

, , +17

Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity

Joy E. Marlo, Colleen M. Niswender, Emily Days et al. · Molecular Pharmacology · 2008 · 149 citations · Full text

, , +17

1–5 of 78